824 related articles for article (PubMed ID: 30526680)
1. Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1
Ye L; Zhang Q; Cheng Y; Chen X; Wang G; Shi M; Zhang T; Cao Y; Pan H; Zhang L; Wang G; Deng Y; Yang Y; Chen G
J Immunother Cancer; 2018 Dec; 6(1):145. PubMed ID: 30526680
[TBL] [Abstract][Full Text] [Related]
2. PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression.
Xiao X; Lao XM; Chen MM; Liu RX; Wei Y; Ouyang FZ; Chen DP; Zhao XY; Zhao Q; Li XF; Liu CL; Zheng L; Kuang DM
Cancer Discov; 2016 May; 6(5):546-59. PubMed ID: 26928313
[TBL] [Abstract][Full Text] [Related]
3. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells.
Lindner S; Dahlke K; Sontheimer K; Hagn M; Kaltenmeier C; Barth TF; Beyer T; Reister F; Fabricius D; Lotfi R; Lunov O; Nienhaus GU; Simmet T; Kreienberg R; Möller P; Schrezenmeier H; Jahrsdörfer B
Cancer Res; 2013 Apr; 73(8):2468-79. PubMed ID: 23384943
[TBL] [Abstract][Full Text] [Related]
5. PD1
Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
[TBL] [Abstract][Full Text] [Related]
6. TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.
Jiang Y; Chen S; Li Q; Liang J; Lin W; Li J; Liu Z; Wen M; Cao M; Hong J
Front Immunol; 2021; 12():612139. PubMed ID: 33679751
[TBL] [Abstract][Full Text] [Related]
7. 14-3-3ζ delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes.
Wang X; Shen H; Zhangyuan G; Huang R; Zhang W; He Q; Jin K; Zhuo H; Zhang Z; Wang J; Sun B; Lu X
Cell Death Dis; 2018 Feb; 9(2):159. PubMed ID: 29415983
[TBL] [Abstract][Full Text] [Related]
8. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
[TBL] [Abstract][Full Text] [Related]
9. Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival.
Qin SK; Li Q; Ming Xu J; Liang J; Cheng Y; Fan Y; Jiang J; Ye H; Tao H; Li L; Zheng L; Wei Z; Li S; Meng K; Ye B; Sun Y
Cancer Sci; 2020 Nov; 111(11):4218-4231. PubMed ID: 32889778
[TBL] [Abstract][Full Text] [Related]
10. Genetic and phenotypic difference in CD8
Wang X; He Q; Shen H; Lu XJ; Sun B
J Med Genet; 2019 Jan; 56(1):18-21. PubMed ID: 29666149
[TBL] [Abstract][Full Text] [Related]
11. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
12. Human regulatory memory B cells defined by expression of TIM-1 and TIGIT are dysfunctional in multiple sclerosis.
Varghese JF; Kaskow BJ; von Glehn F; Case J; Li Z; Julé AM; Berdan E; Ho Sui SJ; Hu Y; Krishnan R; Chitnis T; Kuchroo VK; Weiner HL; Baecher-Allan CM
Front Immunol; 2024; 15():1360219. PubMed ID: 38745667
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor activity and mechanism of oligoclonal hepatocellular carcinoma tumor-infiltrating lymphocytes
Wang WC; Zhang ZQ; Li PP; Ma JY; Chen L; Qian HH; Shi LH; Yin ZF; Sun B; Zhang XF
Cancer Biol Ther; 2019; 20(9):1187-1194. PubMed ID: 31018748
[No Abstract] [Full Text] [Related]
14. Prognostic Role of Immune Cells in Hepatitis B-associated Hepatocellular Carcinoma Following Surgical Resection Depends on Their Localization and Tumor Size.
Wang Q; Luan W; Warren L; Fiel MI; Blank S; Kadri H; Mandeli J; Hiotis SP
J Immunother; 2016 Jan; 39(1):36-44. PubMed ID: 26641260
[TBL] [Abstract][Full Text] [Related]
15. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
[TBL] [Abstract][Full Text] [Related]
16. Expression, immune infiltration and clinical significance of SPAG5 in hepatocellular carcinoma: A gene expression-based study.
Chen W; Chen X; Li S; Ren B
J Gene Med; 2020 Apr; 22(4):e3155. PubMed ID: 31860771
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24
Körber N; Pohl L; Weinberger B; Grubeck-Loebenstein B; Wawer A; Knolle PA; Roggendorf H; Protzer U; Bauer T
Front Immunol; 2021; 12():713351. PubMed ID: 34566969
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA 101368/miR-200a axis modulates the migration of hepatocellular carcinoma through HMGB1/RAGE signaling.
Li S; Gu H; Huang Y; Peng Q; Zhou R; Yi P; Chen R; Huang Z; Hu X; Huang Y; Tang D
Cell Cycle; 2018; 17(19-20):2349-2359. PubMed ID: 30265210
[TBL] [Abstract][Full Text] [Related]
19. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.
Lim CJ; Lee YH; Pan L; Lai L; Chua C; Wasser M; Lim TKH; Yeong J; Toh HC; Lee SY; Chan CY; Goh BK; Chung A; Heikenwälder M; Ng IO; Chow P; Albani S; Chew V
Gut; 2019 May; 68(5):916-927. PubMed ID: 29970455
[TBL] [Abstract][Full Text] [Related]
20. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
